P025. Two-year follow-up with OnabotulinumtoxinA for chronic migraine: a real life evaluation of 113 patients
J Headache Pain
.
2015 Dec;16(Suppl 1):A182.
doi: 10.1186/1129-2377-16-S1-A182.
Authors
Antonio Santoro
1
,
Matteo Tanzi
2
,
Anna Miscio
3
,
Massimiliano Copetti
2
,
Maurizio Leone
3
Affiliations
1
IRCCS, Ospedale Casa Sollievo della Sofferenza, Department of Neurology, San Giovanni Rotondo, (FG), Italy. antoniosantoro2@alice.it.
2
IRCCS, Unit of Biostatistics, Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, (FG), Italy.
3
IRCCS, Ospedale Casa Sollievo della Sofferenza, Department of Neurology, San Giovanni Rotondo, (FG), Italy.
PMID:
28132206
PMCID:
PMC4715072
DOI:
10.1186/1129-2377-16-S1-A182
No abstract available